In this review, we assess the outlook for improving the outcome of cancer therapy by targeting c-FLIP and exploring the possibility of increasing its degradation and/or decreasing its expression in order to provide a potentially safe approach to treat cancer. This evidence concerns the gene CFLAR and cancer.